[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Breast NeoplasmMetastatic Breast CancerRb+ Breast Cancer

Interventions

DRUG

[18F]FLT

\[18F\]FLT PET/CT scan, imaging tracer

DEVICE

PET/CT

\[18F\]FLT PET/CT scan

DRUG

ribociclib

therapeutic

DRUG

paclitaxel

therapeutic

Trial Locations (1)

University of Pennsylvania Hospital, Philadelphia

All Listed Sponsors

lead

University of Pennsylvania

OTHER

NCT02608216 - [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter